Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice
- 1 September 2017
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 83, 19-27
Abstract
No abstract availableKeywords
Funding Information
- Polish-Swiss Research Programme (PSPB-057/2010)
- Polish National Science Centre (UMO-2014/13/D/NZ6/01080)
- Medical University of Warsaw (1M19/PM2/16/16)
- European Commission (STREAM 692190)
This publication has 27 references indexed in Scilit:
- PD-1/PD-L1 blockades in non-small-cell lung cancer therapyOncoTargets and Therapy, 2016
- Emerging roles of lymphatic endothelium in regulating adaptive immunityJournal of Clinical Investigation, 2014
- Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermisAngiogenesis, 2013
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathThe EMBO Journal, 2012
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- PDT-induced inflammatory and host responsesPhotochemical & Photobiological Sciences, 2011
- Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunityApoptosis, 2010
- Vascular and Cellular Targeting for Photodynamic TherapyCritical Reviews™ in Eukaryotic Gene Expression, 2006
- Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic CellsClinical Cancer Research, 2004
- Immunomodulatory aspects of photodynamic therapyExpert Opinion on Investigational Drugs, 1998